Burstable Cannabis Team
Cannabis In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
614 articles
Articles
NRx Pharmaceuticals Advances Toward FDA Approval for NRX-100 Under New Priority Voucher Program
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, is making significant strides in the development and regulatory approval process of NRX-100, its preservative-free intravenous ketamine formulation. The company has recently filed an application under the FDA's newly established Commissioner’s National Priorit...
June 27, 2025Read more
Texas Governor Vetoes Measure to Ban Consumable THC Products
Texas Governor Greg Abbott has vetoed a measure that sought to impose a ban on all consumable THC products within the state, a decision that maintains the availability of THC gummies, vape cartridges, and similar products. This action, taken just before the legislative deadline, averts what would have been one of the most s...
June 26, 2025Read more
Innovative Industrial Properties Inc. Emerges as a Leader in the Evolving Cannabis Industry
The cannabis industry has undergone significant transformation over the past five years, marked by challenges such as excessive spending, stringent tax burdens, and complex regulations. These hurdles have led to a natural selection process, where only the most disciplined and resilient companies have managed to survive. Amo...
June 25, 2025Read more
Missouri's New Cannabis Purchase Limits Spark Industry-Wide Attention
Medical marijuana advocates in Missouri are voicing concerns over newly introduced state guidelines that impose stricter limits on the amount of cannabis patients can purchase from dispensaries. These regulations require dispensaries to closely monitor patient purchases to ensure compliance with monthly allowances, a move t...
June 24, 2025Read more
NRx Pharmaceuticals Enhances Corporate Communications Strategy with IBN to Advance Mental Health Treatments
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, has taken a significant step forward in its mission to develop groundbreaking treatments for mental health conditions such as suicidal depression and PTSD. By engaging InvestorBrandNetwork (IBN) to manage its corporate communications strategy, NRx aims to ampl...
June 24, 2025Read more
Pennsylvania's Budget Debate Could Influence Cannabis Legalization
As Governor Josh Shapiro and Pennsylvania's lawmakers work towards finalizing next year's budget by the July 1 deadline, the cannabis industry watches closely. The budget discussions, marked by disagreements over spending increases between the Democrat-controlled House and Republican-held Senate, could indirectly influence ...
June 23, 2025Read more
High-Security Cannabis Facility Highlights Industry's Growth and Challenges
The presence of a high-security cannabis facility, notable for its barbed wire enclosure and the unmistakable scent of cannabis, near a local sheriff's station, paints a vivid picture of the cannabis industry's current state. This facility, reminiscent of those operated by established entities like Cronos Group Inc. (NASDAQ...
June 20, 2025Read more
Study Highlights Genetic Diversity Concerns in Legal Cannabis Industry
A new study on marijuana genetics has brought to light concerns regarding the legal cannabis industry's impact on the plant's genetic diversity. The industry's emphasis on cultivating faster-growing plants with higher cannabinoid content, primarily driven by economic and regulatory pressures, is leading to a narrower geneti...
June 18, 2025Read more
Psyence Biomed's Chief of Global Impact to Speak at Psychedelic Science 2025
Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, will be a featured speaker at Psychedelic Science 2025 (PS2025), the premier international conference dedicated to psychedelic research, biopharma, medicine, policy, and culture. Organized by the Multidisciplinary Association...
June 18, 2025Read more
Meta's Content Policy Shift Excludes Cannabis, Impacting Industry Visibility
Earlier this year, Meta announced a shift in its approach to handling controversial topics, opting to relax certain content rules around politically debated issues like gender identity and immigration. However, this policy adjustment did not extend to cannabis, with the company maintaining its censorship of search results f...
June 17, 2025Read more
Carolindica Introduces Nano THC Pops: A Summer Game-Changer in Cannabis Consumption
Carolindica, a North Carolina-based leader in the hemp industry, has unveiled its latest innovation, Nano THC Pops, designed to redefine summer cannabis consumption. These freezeable, drinkable, and mixable pops infuse the joy of summer with the benefits of hemp-derived Delta-9 THC, offering a unique blend of nostalgia and ...
June 17, 2025Read more
Congress Shifts Focus to Hemp-Derived THC Restrictions Amid Cannabis Industry Growth
The cannabis industry, a sector that has seen exponential growth and increasing legalization across the United States, is now facing a potential regulatory shift as Congress turns its attention to restricting products made from hemp-derived THC. This move marks a significant departure from previous legislative efforts aimed...
June 16, 2025Read more
Perfect Union to Highlight Community Engagement at Morro Bay Seminar
Perfect Union, a flagship retail brand under MWG Holdings Group, Inc., is set to sponsor and participate in the Breakfast on the Bay seminar hosted by the Morro Bay Chamber of Commerce. The event, titled 'The Art of SLO Living: Embracing the Central Coast Lifestyle,' aims to explore sustainable growth while preserving the u...
June 16, 2025Read more
Illicit Cannabis Sales in the UK Highlight Need for Policy Reform
The recent discovery of stickers promoting illicit cannabis sales in Burton upon Trent, featuring a QR code linking to a website offering various cannabis products, has brought to light the growing issue of unregulated marijuana sales in the UK. This incident not only highlights the accessibility of illegal cannabis but als...
June 13, 2025Read more
Cybin Advances CYB003 into Phase 3 Development, Highlighting Progress in Psychedelic Therapeutics
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has announced a significant milestone in its clinical pipeline with the advancement of CYB003, its lead candidate, into Phase 3 development. This progress underscores the company's commitment to pioneering psychedelic-based therapeutics for mental health conditions. CEO Doug Drys...
June 13, 2025Read more
Federal Immigration Enforcement and the Cannabis Industry: Navigating Compliance Challenges
The intersection of federal immigration enforcement and the cannabis industry presents a unique challenge for businesses operating in states where marijuana has been legalized. Despite the growing acceptance and legalization of marijuana for medical and recreational use across various states, it remains classified as a Sche...
June 12, 2025Read more
Cybin CEO to Discuss Next-Gen Neuropsychiatric Treatments at H.C. Wainwright Conference
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company, has announced that its Chief Executive Officer, Doug Drysdale, will participate in a virtual fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Conference. The event is scheduled for June 16–17, 2025. This participation...
June 12, 2025Read more
NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid National Shortage
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, has taken a significant step towards addressing the current ketamine shortage in the United States by filing an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for NRX-100. This preservative-free formulation of ketamine...
June 12, 2025Read more
CannabisRadio.com Celebrates a Decade of Pioneering Cannabis and Psychedelic Media
For 10 years, CannabisRadio.com has been the pulse of plant-powered progress—amplifying stories of innovation, advocacy, and wellness across cannabis, plant medicine, and biohacking. A decade in, the mission continues: elevate the conversation, evolve the culture.
June 12, 2025Read more
Missouri Launches Initiative to Ensure Cannabis Product Safety
Starting next month, Missouri's Division of Cannabis Regulation will implement a new safety initiative, conducting unannounced visits to dispensaries to collect and test cannabis products for harmful contaminants. This move is designed to ensure that products available to consumers meet safety standards, testing for pestici...
June 11, 2025Read more
Silo Pharma Secures U.S. Patent for PTSD Treatment Biomarkers, Advancing Clinical Trials
Silo Pharma (NASDAQ: SILO) has achieved a pivotal milestone with the U.S. Patent and Trademark Office issuing a Notice of Allowance for its licensed patent application concerning biomarkers for evaluating prophylactic treatments for stress-induced affective disorders. This patent, designated as U.S. Patent No. 12,329,726 an...
June 11, 2025Read more